The parasite that causes malaria has evolved to evade many of the drugs that researchers have developed to fight the tropical disease.

Plasmodium falciparum has shown an ability to evade everything we throw at it, most recently artemisinin-based combination therapies, today’s front-line treatment.

Researchers efficiently clear mice of the parasites that cause leishmaniasis, Chagas disease, and sleeping sickness by inhibiting the parasites’ kinetoplastid proteasomes.

Cases of the mosquito-borne infection are on the rise, with most reported in Brazil. The U.S. has confirmed at least two cases to date, including a recent importation into Texas.

Researchers warn that a poorly understood, life-threatening tropical disease may be killing thousands more people than previously realized.

A plant used in traditional Mayan remedies to cure the parasitic infection produces a potent compound.

The microbial contents of sand fly stomachs may have important consequences for the spread of leishmaniasis.

The olfactory receptor neurons of some mosquitoes become less sensitive to the insect repellent after previous exposure.

A public-private partnership including 13 pharmaceutical companies pledge more than $785 million to fight neglected tropical diseases.